Day One Biopharmaceuticals
DAWN
DAWN
165 hedge funds and large institutions have $1.28B invested in Day One Biopharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 68 increasing their positions, 36 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
6% more funds holding
Funds holding: 156 → 165 (+9)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
48% less call options, than puts
Call options by funds: $2.17M | Put options by funds: $4.16M
Holders
165
Holding in Top 10
2
Calls
$2.17M
Puts
$4.16M
Top Buyers
| 1 | +$66.2M | |
| 2 | +$43.2M | |
| 3 | +$25.6M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.6M |
| 5 |
VPC
Vestal Point Capital
New York
|
+$17.4M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$7.39M | |
| 3 | -$6.48M | |
| 4 |
DM
Deerfield Management
New York
|
-$4.25M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$2.76M |